Key facts
- SurgeryAI’s last known valuation is $4.4M (Mar 2026).
- It has raised $400K; the latest was Seed Round ($360K) in Mar 2026.
- Notable investors include Innovate UK, Rockstart, Imperial Enterprise Lab, South East Angels, The Hill.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for SurgeryAI
- ·The full record, as it builds
Funding rounds
No funding rounds for SurgeryAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SurgeryAI
Developer of an AI-based healthcare operations platform designed to support surgical scheduling and capacity planning in hospitals. The company offers predictive models that use historical procedure data to estimate procedure duration and generate feasible schedules under operational constraints, enabling hospitals and surgical teams to plan operating room capacity more accurately and reduce scheduling conflicts.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 3
- Website
- surgeryai.com/
- Ownership
- Privately Held (backing)
SurgeryAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SurgeryAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SurgeryAI in its N-PORT filings yet. We sweep new filings monthly.